ZA748128B - A method of contraception by the administration of stage combination preparations - Google Patents

A method of contraception by the administration of stage combination preparations

Info

Publication number
ZA748128B
ZA748128B ZA00748128A ZA748128A ZA748128B ZA 748128 B ZA748128 B ZA 748128B ZA 00748128 A ZA00748128 A ZA 00748128A ZA 748128 A ZA748128 A ZA 748128A ZA 748128 B ZA748128 B ZA 748128B
Authority
ZA
South Africa
Prior art keywords
contraception
administration
combination preparations
stage combination
stage
Prior art date
Application number
ZA00748128A
Other languages
English (en)
Inventor
A Pitchford
U Lachnit-Fixson
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA748128B publication Critical patent/ZA748128B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ZA00748128A 1973-12-21 1974-12-20 A method of contraception by the administration of stage combination preparations ZA748128B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2365103A DE2365103C3 (de) 1973-12-21 1973-12-21 V erwendung von Hormonen zur Kontrazeption

Publications (1)

Publication Number Publication Date
ZA748128B true ZA748128B (en) 1976-01-28

Family

ID=5902211

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00748128A ZA748128B (en) 1973-12-21 1974-12-20 A method of contraception by the administration of stage combination preparations

Country Status (13)

Country Link
US (1) US3957982A (es)
BE (1) BE823689A (es)
CA (1) CA1029303A (es)
CY (1) CY1065A (es)
DE (1) DE2365103C3 (es)
DK (1) DK155308C (es)
GB (1) GB1490099A (es)
HK (1) HK47080A (es)
KE (1) KE3059A (es)
MY (1) MY8100118A (es)
NL (1) NL178845C (es)
SE (1) SE441233B (es)
ZA (1) ZA748128B (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292315A (en) * 1977-12-30 1981-09-29 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
DE3029726A1 (de) * 1980-08-06 1982-02-25 Werner Dr.med. 4400 Münster Steinschulte Postkoitale kontrazeptiva mit norgestrel oder levonorgestrel
US4425339A (en) 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
AU582540B2 (en) * 1983-08-05 1989-04-06 Pre Jay Holdings Ltd. A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
DE3347125A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
US4610687A (en) * 1984-08-06 1986-09-09 Board Of Trustees Operating Michigan State University Method for breeding control in female bovines
US5010070A (en) * 1987-06-15 1991-04-23 Warner-Lambert Company Graduated estrogen contraceptive
US4816257A (en) * 1985-09-20 1989-03-28 Research & Education Institute, Harbor-Ucla Medical Center Inc. Method for producing an in vivo environment suitable for human embryo transfer
US4958736A (en) * 1986-03-18 1990-09-25 Gynex, Inc. Package for oral contraceptive tablet
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
DK174724B1 (da) † 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
CA1336328C (en) * 1988-04-11 1995-07-18 Walter G. Leonard Method of increasing bone density in humans
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive
ES2229378T3 (es) * 1996-07-26 2005-04-16 Wyeth Anticonceptivo oral.
US6479475B1 (en) 1996-07-26 2002-11-12 Wyeth Oral contraceptive
US6451778B1 (en) 1996-07-26 2002-09-17 Wyeth Oral contraceptive
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6214815B1 (en) 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US20050038006A1 (en) * 1998-12-23 2005-02-17 Shangold Gary A. Triphasic oral contraceptive
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6660726B2 (en) * 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
DE10045380A1 (de) 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
EP1853272A1 (en) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
US11376263B2 (en) 2020-10-08 2022-07-05 Fortress Biotech, Inc. Cyproterone acetate compositions and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6615481A (es) * 1966-11-02 1968-05-03
US3568828A (en) * 1967-03-01 1971-03-09 Squibb & Sons Inc Modified sequential oral contraceptive
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US3795734A (en) * 1970-04-20 1974-03-05 American Home Prod Cyclic regimen of hormone administration for contraception
US3733407A (en) * 1971-08-25 1973-05-15 Syntex Corp Menopause treatment
DE2310963A1 (de) * 1972-04-14 1974-09-05 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
DE2335265A1 (de) * 1973-07-09 1975-01-30 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten

Also Published As

Publication number Publication date
CA1029303A (en) 1978-04-11
CY1065A (en) 1980-10-24
DE2365103B2 (de) 1979-12-20
KE3059A (en) 1980-07-11
NL178845C (nl) 1986-06-02
NL7416807A (nl) 1975-06-24
NL178845B (nl) 1986-01-02
DK667674A (es) 1975-09-08
BE823689A (fr) 1975-06-20
US3957982A (en) 1976-05-18
DK155308B (da) 1989-03-28
DK155308C (da) 1989-08-28
HK47080A (en) 1980-09-05
SE441233B (sv) 1985-09-23
DE2365103C3 (de) 1980-08-28
AU7670874A (en) 1976-06-24
SE7416039L (es) 1975-06-23
GB1490099A (en) 1977-10-26
MY8100118A (en) 1981-12-31
DE2365103A1 (de) 1975-07-10

Similar Documents

Publication Publication Date Title
ZA748128B (en) A method of contraception by the administration of stage combination preparations
ZA741963B (en) Oral drug preparations
CA1032427A (en) Therapeutic stocking
MY7800234A (en) Novel triamcinolone derivative
ZA744412B (en) Method of contraception by the administration of stage-combination preparations
MW4674A1 (en) A process for the preparation of poly-n-alkyl-iminoalanes
IL45870A0 (en) Vaccine preparations
AU455685B2 (en) A process for the preparation of 6-meethyl-19-nor-pregnenes
IL45139A (en) Substituted nitrobenzophenone derivatives and a process for the preparation thereof
ZA743343B (en) New phatmaceutical preparations
IL45087A0 (en) Corticoid-containing inhalant preparations
AU8487175A (en) Pharmaceutical preparations
CA1013674A (en) Method of contraception by the administration of stage-combination preparations
ZA748179B (en) Ophthlamic preparations
ZA745332B (en) Oral preparations
CS187407B2 (en) Method of preparation of the anthelmintic means
AU493201B2 (en) Method of contraception bythe administration of stage combination preparations
AU483202B2 (en) Method of contraception bythe administration of stage-combination preparations
AU7569174A (en) Pharmaceutical preparations
MY8100184A (en) Pharmaceutical preparations
GB1405681A (en) Amyrin derivatives
CA914148A (en) Preparation of 9, 11-dichloro steroids
AU479744B2 (en) Method of contraception by the aministration of stage-combustion preparations
ZA735865B (en) Method for the preparation of derivatives of 5-hydroxy-2-carboxychromone
PH9238A (en) Method for the preparation of derivatives of 5-hydroxy-2-carboxychromone